Wellmune WGP Beta-Glucan reduces cold & flu symptoms

Typical cold and flu (upper respiratory tract Infections, URTI) are caused by rhinovirus and influenza viruses. In multiple studies Wellmune WGP has reduced URTI symptoms and improved overall physical health. Wellmune WGP is a food ingredient that can enhance the ability of the immune system to maintain good health. There is an extensive body of published, peer reviewed science that has demonstrated the safety, mechanism of action and effectiveness of Wellmune WGP in shortening the duration and severity of upper respiratory tract symptoms in both well and stressed subjects.

• The mechanism of action of Wellmune WGP is demonstrated in several peerreviewed publications
• Toxicology data supporting safety of Wellmune WGP is published
• Published pre-clinical data provides proof of concept on ingredient efficacy
• Six published human clinical studies support efficacy of Wellmune WGP against symptoms of cold & flu
• Biothera continues it long-term commitment to research on Wellmune's clinical outcomes and correlating biomarkers

(This paper is co-authored by: Dr John Blocher, Assistant Vice President R&D, Biothera Inc)